We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Medical Mktg | MMG | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 3.75 | 01:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 3.75 |
| Top Posts |
|---|
Posted at 21/2/2010 09:51 by tenapen I did not go to any Presentations so if you are not his Pal but another investor that was 'smooth talked' into beleaving that MMG had the answer, i am sorry for saying so. Do not feel bad for being taken in, as the then great Mr Mike Walters also beleaved all that the Bests said and became a cheif cheerleader.As for the DNA trials, they were about two years late when the company failed so my guess is that the results they were getting were not ..... the right results so they tried again !. Keep beleaving that the administrators are going to do more than liquidate the assets and sell the technologys to the highest bidder and after deducting their bill share the money raised to share holders. This will meen the smalll holders get Jack sh*t. Jura1, the next time you see 'them' please ask why they would not deal with the new board to raise new money and change the name of the company (as MMG was surely tarnished) and in not doing we all lost money, even the Bests !. |
Posted at 20/2/2010 19:14 by jura1 You've got it so wrong. How many MMG meetings and presentations have you attended over the years? What is the the full story then between DB and the board because I certainly do not know.I only posted to help explain about the role of an administrator. The company is insolvent, i.e. it cannot pay its immediate debts, but it does not necessarily mean it needs to be wound up. Companies have re-risen as solvent entities from administration. This is why the administrators should be aware of the DNA trial results as this would have finished about the same time (Sept 09) as MMG went into administration. This was the information all investors were waiting for but I see no mention of it at all |
Posted at 21/7/2009 16:33 by tenapen Benny,IMO the game is over for MMG. The A1 Gasbag exaggerated all aspects of developement and as such drained investor confidence. The many 'babybio's' have all failed to deliver and that is just from the test tube they have never even got close to clinical trails. The 'credit crunch' will not have helped but IMO a further fund raising would have been out of the question. I made some money and lost some money on MMG as i hope other investors have. regards. |
Posted at 07/7/2009 16:47 by jamie62 sleeping giant - any news on Big Phil's investor/shareholder presentation ? |
Posted at 01/7/2009 21:56 by jamie62 not sure i have received my invite to the shareholder presentationbut from their website, i see the prelims are due soon - - sounds like the begging bowl might be being handed around ..is there going to be a rights issue to follow, once investor & shareholder sentiment is known? |
Posted at 01/7/2009 20:52 by sleepinggiant Jamie62, Sorry maybe a silly question but interviews with other co's? I hear Phil Cartmell is doing investor/shareholder presentations next week... |
Posted at 08/6/2009 22:33 by el magnifico Quick overview of the bull case:The negatives on MMG are now well over a year old - trashed share price; close-up funding horizon; Bests' outside the tent with big shareholding; continued lack of newsflow; smaller biotech meltdown as the least favoured equity asset class (that one even before the credit crisis showed up!) I guess I'm holding on for a positive surprise. The nice thing is - just one bit of good news should do the trick, given the drip-feed of gloom and doom. Without wishing to lapse into Best-speak : why not a simple, underpriced jv with Big Pharma in either GenVax or ruthenium to shore up finances - and a share price which rises like 2003-2005 (20p to 300p), to boot ? That's the power which equities have to create wealth - but which investors may have forgotten in the wrack and ruin of the credit crisis. el |
Posted at 05/6/2009 07:56 by ningram If MMG technology is so desirable then a buyer, partner or possibly investor could seek to settle up with DB if that will take things forward. Perhaps things are not all doom and gloom which is why DB is holding out. We live in hope! |
Posted at 01/6/2009 08:27 by bennytheball el magnifico, why is silence golden?I've also been wondering about parternships and deals as a way forward. MMG market cap looks ridiculously low if one assumes the technology is as promising as ever. Institutional fund raising I assume hard in current circumstances, although maybe I'm wrong there. Maybe institutions are cash rich and scouring for bargains currently? Then again, I wonder if MMG are still out of favour, and/or existing investors are around their limit for holdings in terms of % of the company? So I keep imagining a deal of some sort as the way forward, maybe with Big Pharma, maybe something more of a rabbit out of the hat... What's your money on? b |
Posted at 21/5/2009 18:59 by bennytheball What sort of disadvantage to non-nstitutional investors do you have in mind? |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
